• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

“RADIANCE-1” Study: Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia

  • — 27 Mar, 2007
AudioMedica News
AudioMedica News
"RADIANCE-1" Study: Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia
"RADIANCE-1" Study:  Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia
00:00 /
RSS Feed
Share
Link
Embed
John Kastelein

JOHN KASTELEIN, Academic Medical Center, Amsterdam

REFERENCE: Abstract 407-7, American College of Cardiolgy New Orleans
A drug which raises HDL and reduces circulating levels of LDL has nevertheless failed to reduce atherosclerotic progression in patients with familial hypercholesterolemia. This disappointing outcome of a study using the cholesteryl ester transfer protein inhibitor (CETP), torcetrapib, was announced at the American College of Cardiology meeting in New Orleans. John Kastelein discussed the findings, and their implications for therapies targeting HDL, with Peter Goodwin.

[audio:https://www.audiomedica.com/podcasting/cardio/acc2007/070327_john_kastelein.mp3]

You may also like...

  • Patients with High Restenosis Risk Benefit More from Drug Eluting Stents Patients with High Restenosis Risk Benefit More from Drug Eluting Stents 5 Sep, 2007
  • Surgical Ventricular Reconstruction—No Benefit On Top Of Coronary Artery Bypass Grafting In Patients With Severe Heart Failure Surgical Ventricular Reconstruction—No Benefit On Top Of Coronary Artery Bypass Grafting In Patients With Severe Heart Failure 1 Apr, 2009
  • Audio Journal of Cardiovascular Medicine: September 5th 2006 Audio Journal of Cardiovascular Medicine: September 5th 2006 5 Sep, 2006
  • The Wingspan Stent: Safe Intra-Cranial Angioplasty? The Wingspan Stent: Safe Intra-Cranial Angioplasty? 9 Feb, 2007
  • Previous story “ERASE” Trial: Infusions of Reconstituted HDL Treat Atherosclerosis in Patients with Acute Coronary Syndromes
  • Next story Direct Renin Inhibitor Combined with Angiotensin Receptor Blockade Gives Additional Blood Pressure Lowering
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • Microbiome Diversity Key To Survival After Allogeneic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Which Tasks Most Influence Pediatric PT Productivity,…
    • New Front Line Standard for Older Patients with Chronic…
  • Home
  • Cardiovascular
  • “RADIANCE-1” Study: Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.